Related Experiment Video
Updated: Jan 29, 2026

Author Spotlight: Hickman Catheter Use for Long-Term Vascular Access in a Preclinical Swine Model
Published on: March 31, 2023
The economic issue of vascular access within the Japanese medical reimbursement system
Yoshiaki Takemoto1, Toshihide Naganuma1
1Department of Urology, Osaka City University Graduate School of Medicine, Osaka - Japan.
Insights
Vascular access (VA) costs in Japan reach JPY20 billion annually, similar to the US. Percutaneous transluminal angioplasty (PTA) is increasingly vital for chronic renal failure treatment.
Area of Science:
- Health Economics
- Nephrology
- Vascular Surgery
Background:
- Vascular access (VA) is crucial for chronic renal failure (CRF) patients undergoing dialysis.
- Understanding the economic burden of VA procedures is essential for healthcare planning.
Purpose of the Study:
- To analyze the current health economics of VA procedures in Japan.
- To compare VA-related healthcare costs in Japan with those in the USA.
- To evaluate the trend and significance of percutaneous transluminal angioplasty (PTA) in VA procedures for CRF.
Main Methods:
- Analysis of VA-related medical expenses in Japan.
- Comparison with United States Renal Data System (USRDS) statistics for the USA.
- Examination of the proportion and trend of PTA among VA procedures.
Main Results:
- Yearly VA-related medical expenses in Japan amount to JPY20 billion, representing 1.4% of total CRF healthcare costs.
- VA-related costs in Japan are comparable to the 1.2% seen in the USA.
- Percutaneous transluminal angioplasty (PTA) constitutes approximately 60% of VA procedures in Japan, with this proportion increasing annually.
Conclusions:
- Health economics of VA procedures in Japan are substantial and comparable to the US.
- The increasing utilization of PTA suggests its growing importance in managing CRF.
- Societal aging and extended treatment durations are likely to further elevate the significance of PTA for CRF patients in Japan.
Abstract:
We analyzed the current health economics of vascular access (VA) procedures in Japan. Results showed that the yearly VA-related medical expenses were as high as JPY20 billion and accounted for 1.4% of the total healthcare cost for chronic renal failure. The United States Renal Data System (USRDS) statistics showed that in the USA the yearly VA-related medical expenses accounted for 1.2% of the total medical cost for chronic renal failure, indicating that the costs did not differ much between the two countries. Moreover, percutaneous transluminal angioplasty (PTA) accounts for approximately 60% of VA procedures performed in Japan, and this ratio is increasing every year. Due to the aging of society and longer treatment periods, it is thought that PTA will become a significant procedure for the treatment of chronic renal failure in Japan.
More Related Videos
Related Concept Videos
Myocarditis III: Medical Management
Endocarditis III: Medical Management
Ethical Issues
Ethical Concerns in Healthcare:
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Inhaled Medications
Seedless Vascular Plants

